Allurion Technologies (ALURW) Net Margin (2022 - 2026)

Allurion Technologies (ALURW) reported Net Margin of 206.82% for Q1 2026, down 33906.0% on a YoY basis from N/an in Q1 2025, and down 132.46% quarter-over-quarter from 637.14% in Q4 2025.

Allurion Technologies (ALURW) Net Margin (2022 - 2026) Analysis & Trends

Allurion Technologies has reported Net Margin for 5 years, with the latest figure at 206.82% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 33906.0% year-over-year to 206.82%; the trailing twelve-month figure through Mar 2026 stood at 34.09% (down 2767.0% YoY), and the FY2025 full-year result was 2.28%, up 2470.0% from the prior year.
  • Net Margin for Q1 2026 stood at 206.82%, down from 637.14% in the prior quarter.
  • The five-year high for Net Margin was 637.14% in Q4 2025, with the low at 447.1% in Q3 2025.
  • Historically, Net Margin has averaged 68.83% across 5 years, with a median of 104.65% in 2023.
  • The largest YoY upside for Net Margin was 80899 bps in 2025 against a maximum downside of 60988 bps in 2025.
  • Allurion Technologies' Net Margin stood at 68.18% in 2022, then slumped by 281 bps to 259.74% in 2023, then soared by 34 bps to 171.85% in 2024, then surged by 471 bps to 637.14% in 2025, then slumped by 132 bps to 206.82% in 2026.
  • The last three Net Margin figures came in at 206.82% (Q1 2026), 637.14% (Q4 2025), and 447.1% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.65%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.38%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 12.75%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 8.01%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Allurion Technologies - - 1.23 Mn -206.82%

Historic Data

Download Data
DateValue
Mar 31, 2026 -206.82%
Dec 31, 2025 637.14%
Sep 30, 2025 -447.10%
Jun 30, 2025 -276.27%
Mar 31, 2025 132.24%
Dec 31, 2024 -171.85%
Sep 30, 2024 162.77%
Jun 30, 2024 -70.73%
Mar 31, 2024 21.27%
Dec 31, 2023 -259.74%
Sep 30, 2023 -120.25%
Jun 30, 2023 -175.32%
Mar 31, 2023 -131.60%
Dec 31, 2022 -68.18%
Sep 30, 2022 -89.05%
Jun 30, 2022 -37.72%